Skip to main content
ToolGen Incorporated logo

ToolGen Incorporated — Investor Relations & Filings

Ticker · 199800 ISIN · KR7199800004 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2025-12-23 Regulatory Filings
Country KR South Korea
Listing KO 199800

About ToolGen Incorporated

http://www.toolgen.com/eng

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. Founded in 1999, the company has developed multiple generations of gene editing tools, including Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen is a key patent holder for CRISPR-Cas9 technology, being the first to file a patent for its application in eukaryotic cells. The company's business model focuses on developing therapeutics and agricultural products, as well as monetizing its intellectual property through licensing and collaborations. Its primary mission is to translate genetic knowledge into transformative products for biomedicine and agriculture.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Regulatory Filings Classification · 1% confidence The document is a formal announcement regarding the scheduling and details of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a general corporate disclosure of an upcoming event.
2025-12-23 Korean
전환청구권행사
Regulatory Filings
2025-11-06 Korean
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Regulatory Filings
2025-10-10 Korean
조회공시요구(현저한시황변동)
Regulatory Filings
2025-10-02 Korean
전환청구권행사
Regulatory Filings
2025-10-01 Korean
전환청구권행사
Share Issue/Capital Change Classification · 1% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares to be issued, the conversion price, and the remaining balance of convertible bonds. This type of filing relates to changes in the company's capital structure due to the conversion of debt into equity, which falls under the 'Share Issue/Capital Change' category.
2025-09-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.